In a 61‑year‑old woman with chronic lower‑quadrant abdominal pain, weight loss, altered bowel habits, a positive fecal immunochemical test and persistent microscopic hematuria despite prior normal colonoscopy and endoscopy, what are the likely causes of the ongoing blood in stool and urine?

Persistent Blood in Stool and Urine: Likely Causes and Workup

This patient requires urgent repeat colonoscopy within 2 weeks given her age >50, positive FIT, and concerning symptoms including weight loss—she is at significant risk for colorectal malignancy that may have developed since her last colonoscopy 2-3 years ago. 1

Why Blood Persists After Prior Normal Studies

Colorectal Source (Most Likely)

• Interval development of colorectal cancer or advanced adenomas is the primary concern. Approximately 6% of patients with lower GI bleeding have underlying bowel cancer, and your patient's positive FIT combined with alarm features (weight loss, age >61) places her in a high-risk category requiring colonoscopy within 2 weeks 1

• Prior normal colonoscopy does not exclude current pathology. Cancers and advanced adenomas can develop in the 2-3 year interval since her last examination. The positive FIT has 71.7% sensitivity for advanced neoplasia overall, but importantly detects 93.9% of colorectal cancers 2

• Small bowel lesions may explain positive FIT when colonoscopy is normal. Studies show that 51% of patients with obscure GI bleeding and positive FIT have significant small bowel lesions on capsule endoscopy, with mean fecal hemoglobin of 345.6 ng/ml in those with lesions versus 25.0 ng/ml in those without 3

Urologic Source (Concurrent Issue)

The persistent microscopic hematuria requires separate urologic evaluation with risk stratification. 1

• Bladder cancer is the most common malignancy detected in patients with hematuria and is optimally diagnosed with cystoscopy, not imaging alone. Delays in bladder cancer diagnosis increase cancer-specific mortality by 34% 1

• Her risk factors warrant full urologic workup: age 61, female sex, and persistent hematuria over 2-3 years. The 2025 AUA/SUFU guidelines emphasize that 2.6-4% of patients with microscopic hematuria have urologic malignancy, rising to 25.8% in at-risk populations 1, 4

• Standard evaluation includes: detailed smoking history, cystoscopy, upper tract imaging (CT urogram preferred), and consideration of urine-based tumor markers. The small gallstone is incidental and unrelated 1

Critical Pitfalls to Avoid

• Do not assume prior normal studies exclude current pathology. The 2-3 year interval is sufficient for development of significant lesions 1

• Do not attribute positive FIT solely to hemorrhoids or diverticulosis without complete visualization. These are "presumed sources" with low diagnostic certainty 1

• Do not delay colonoscopy beyond 2 weeks in this high-risk patient. British Society of Gastroenterology guidelines specifically mandate this timeframe for patients >50 with unexplained rectal bleeding 1

• Do not use imaging alone for hematuria evaluation. Cystoscopy is essential as most hematuria-related cancers are bladder cancers that imaging may miss 1

Immediate Action Plan

1. Schedule colonoscopy within 2 weeks (not routine timing) given positive FIT, age, weight loss, and alarm symptoms 1

2. Ensure adequate bowel preparation with polyethylene glycol solution, which provides higher diagnostic yields than enemas 1

3. Concurrent urologic referral for cystoscopy and CT urogram to evaluate persistent hematuria separately from GI workup 1

4. If colonoscopy is normal again, strongly consider capsule endoscopy to evaluate small bowel as source of positive FIT 3

5. Measure blood pressure and serum creatinine to assess for medical renal disease as alternative cause of hematuria 1

Why Both Systems May Show Blood

These are likely two separate pathologic processes requiring parallel investigation rather than a single unifying diagnosis. The positive FIT indicates GI blood loss (most concerning for colorectal neoplasia given her risk profile), while persistent microscopic hematuria suggests urologic pathology (bladder cancer being most critical to exclude). The small fibroids are unlikely contributors to either finding 1.